The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
2025 · Nature Medicine · 53 citations
https://doi.org/10.1038/s41591-025-03834-0
F
Farhad Imam
Gates Foundation(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
2.2K
Citations
12
h-index
13
i10-index
Farhad Imam is an academic researcher from Gates Foundation. The author has contributed to research in topics: Alzheimer's disease research and treatments & Bioinformatics and Genomic Networks & Metabolomics and Mass Spectrometry Studies. The author has an h-index of 12, co-authored 32 publications.
ORCID: 0000-0003-2854-2568Papers by this author
worksA homozygous founder mutation in <i>TRAPPC6B</i> associates with a neurodevelopmental disorder characterised by microcephaly, epilepsy and autistic features
2017 · Journal of Medical Genetics · 48 citations
https://doi.org/10.1136/jmedgenet-2017-104627
APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases
2025 · Nature Medicine · 45 citations
https://doi.org/10.1038/s41591-025-03835-z
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases
2025 · Nature Medicine · 14 citations
https://doi.org/10.1038/s41591-025-03833-1
Transcriptome analysis of severe hypoxic stress during development in zebrafish
2015 · Genomics Data · 9 citations
https://doi.org/10.1016/j.gdata.2015.07.025
Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer’s disease
2025 · Research Square · 1 citations
https://doi.org/10.21203/rs.3.rs-7089423/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat